SOPHIRIS BIO INC. (SPHS) [Rocket]

Overview

SOPHIRIS BIO INC. (SPHS)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
09/01/2022	SEC STAFF ACTION	Form SEC STAFF ACTION - SEC Staff Action: ORDER
04/29/2020	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
04/03/2020	8-K	Other Events
03/31/2020	8-K	Quarterly results
03/11/2020	8-K	Quarterly results
03/10/2020	GN	Sophiris Bio Announces Nasdaq Delisting
02/14/2020	SC 13G/A	ARMISTICE CAPITAL, LLC reports a 5% stake in Sophiris Bio Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11
Revenues	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0
Revenue growth					-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0
Gross margin						100.0%
Research and development	10.7	6.2	3.5	9.9	24.7	10.3	13.5	8.7
General and administrative	4.4	5.7	6.8	3.6	5.3	4.5	5.7	4.6
EBITA	-6.4	-8.6	-11.0	-13.5	-30.0	-9.1	-19.3	-13.1
EBITA margin						-182.0%
Amortization of intangibles							0.1	0.2
EBIT	-6.4	-8.6	-11.0	-13.5	-30.0	-9.1	-19.4	-13.3
EBIT margin						-182.0%
Pre-tax income	-6.8	-8.6	-11.2	-14.2	-30.7	-10.6	-21.2	-14.2
Income taxes	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%		0.0%	0.0%
Net income	-6.8	-8.6	-11.2	-14.2	-30.7	-11.1	-21.2	-14.2
Net margin						-223.0%

Diluted EPS	($0.23)	($0.29)	($0.49)	($0.84)	($1.85)	($1.39)	($6.94)	($6.06)
Shares outstanding (diluted)	30.1	30.1	23.0	16.9	16.6	8.0	3.1	2.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.